Heterogeneous Cardiovascular Effects of SGLT2 Inhibitors in Type 2 Diabetes: A Causal Forest and Target Trial Emulation Study

Mori Y, Komura T, Adomi M, Yagi R, Fukuma S, Kawakami K, Kondo N, Tsugawa Y, Yabe D, Yanagita M, Inoue K. Heterogeneous Cardiovascular Effects of SGLT2 Inhibitors in Type 2 Diabetes: A Causal Forest and Target Trial Emulation Study. Eur J Prev Cardiol. 2025 Sep 1:zwaf539. doi: 10.1093/eurjpc/zwaf539. Epub ahead of print. PMID: 40889271.


Related Posts